B

Biosino Bio-Technology and Science Inc
HKEX:8247

Watchlist Manager
Biosino Bio-Technology and Science Inc
HKEX:8247
Watchlist
Price: 0.85 HKD
Updated: May 22, 2024

Cash Flow Statement

Cash Flow Statement
Biosino Bio-Technology and Science Inc

Rotate your device to view
Cash Flow Statement
Currency: CNY
Dec-2005 Jun-2006 Dec-2006 Jun-2007 Dec-2007 Jun-2008 Dec-2008 Jun-2009 Dec-2009 Jun-2010 Dec-2010 Jun-2011 Dec-2011 Jun-2012 Dec-2012 Jun-2013 Dec-2013 Jun-2014 Dec-2014 Jun-2015 Dec-2015 Jun-2016 Dec-2016 Jun-2017 Dec-2017 Jun-2018 Dec-2018 Jun-2019 Dec-2019 Jun-2020 Dec-2020 Jun-2021 Dec-2021 Jun-2022 Dec-2022 Jun-2023 Dec-2023
Operating Cash Flow
Net Income
30
0
28
0
29
0
0
0
0
0
0
0
0
0
0
0
0
0
14
0
3
0
22
0
25
0
(15)
0
(115)
0
2
0
6
0
19
0
(18)
Depreciation & Amortization
4
0
9
0
12
0
0
0
0
0
0
0
0
0
0
0
0
0
19
0
20
0
19
0
22
0
25
0
33
0
25
0
28
0
24
0
20
Other Non-Cash Items
1
0
3
0
5
0
0
0
0
0
0
0
0
0
0
0
0
0
2
0
4
0
15
0
(10)
0
13
0
129
0
(10)
0
22
0
5
0
(0)
Cash Taxes Paid
4
0
4
0
7
0
8
0
5
0
5
0
5
0
0
0
0
0
2
0
2
0
4
0
2
0
2
0
1
0
0
0
3
0
5
0
6
Cash Interest Paid
0
0
4
0
6
0
6
0
1
0
0
0
2
0
0
0
0
0
0
0
0
0
3
0
7
0
14
0
14
0
10
0
11
0
6
0
5
Change in Working Capital
(18)
(23)
(1)
1
(16)
(19)
46
60
54
48
41
14
32
63
7
(7)
10
0
(22)
30
6
10
(13)
52
(28)
61
(19)
(18)
(16)
(4)
(6)
46
(7)
28
(3)
19
(8)
Cash from Operating Activities
18
N/A
12
-30%
38
+209%
40
+6%
30
-24%
27
-10%
46
+68%
60
+30%
54
-11%
48
-10%
41
-15%
14
-67%
32
+135%
63
+98%
7
-88%
(7)
N/A
10
N/A
0
-98%
13
+7 911%
30
+138%
33
+10%
10
-70%
42
+318%
52
+22%
9
-82%
61
+566%
4
-93%
(18)
N/A
31
N/A
(4)
N/A
11
N/A
46
+305%
49
+6%
28
-43%
45
+59%
19
-58%
(7)
N/A
Investing Cash Flow
Capital Expenditures
(32)
0
(12)
0
(20)
0
0
0
0
0
0
0
0
0
0
0
0
0
(18)
0
(15)
0
(41)
0
(180)
0
(41)
0
(18)
0
(16)
0
(7)
0
(16)
0
(17)
Other Items
(1)
2
(0)
8
(1)
(30)
(45)
(6)
8
(2)
(43)
(47)
(70)
(53)
(47)
(37)
27
17
2
(27)
(15)
(93)
(136)
(169)
100
(60)
6
(4)
70
61
0
(21)
1
8
15
(15)
(1)
Cash from Investing Activities
(33)
N/A
(30)
+9%
(12)
+61%
(4)
+69%
(21)
-473%
(49)
-138%
(45)
+9%
(6)
+86%
8
N/A
(2)
N/A
(43)
-1 838%
(47)
-9%
(70)
-50%
(53)
+24%
(47)
+12%
(37)
+21%
27
N/A
17
-36%
(16)
N/A
(27)
-69%
(30)
-10%
(93)
-215%
(177)
-90%
(169)
+5%
(81)
+52%
(60)
+26%
(35)
+41%
(4)
+88%
51
N/A
61
+19%
(16)
N/A
(21)
-34%
(6)
+73%
8
N/A
(1)
N/A
(15)
-1 238%
(18)
-18%
Financing Cash Flow
Net Issuance of Common Stock
0
0
62
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
32
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Net Issuance of Debt
40
0
50
0
(0)
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
2
0
111
0
40
0
40
0
(42)
0
33
0
(33)
0
(26)
0
(1)
Cash Paid for Dividends
(33)
0
(10)
0
(10)
0
0
0
0
0
0
0
0
0
0
0
(16)
0
(15)
0
(13)
0
(13)
0
(14)
0
(14)
0
(13)
0
(1)
0
0
0
0
0
0
Other
(0)
62
(12)
(87)
(5)
3
(65)
(94)
(51)
(13)
69
58
15
(12)
(48)
(16)
0
1
3
(13)
(3)
67
39
132
(7)
0
(4)
(29)
(16)
(19)
(12)
(51)
(11)
(22)
15
15
11
Cash from Financing Activities
6
N/A
68
+1 030%
90
+32%
16
-83%
(16)
N/A
(8)
+51%
(65)
-751%
(94)
-46%
(51)
+46%
(13)
+74%
69
N/A
58
-17%
15
-74%
(12)
N/A
(48)
-289%
(16)
+66%
(16)
+4%
(16)
-1%
(11)
+27%
(13)
-13%
(14)
-6%
67
N/A
169
+153%
132
-22%
19
-86%
0
-99%
22
+16 811%
(29)
N/A
(71)
-144%
(19)
+73%
20
N/A
(51)
N/A
(44)
+14%
(22)
+49%
(11)
+52%
15
N/A
10
-30%
Change in Cash
Effect of Foreign Exchange Rates
0
0
0
0
0
0
0
0
0
0
(1)
0
(2)
0
0
0
0
0
(0)
0
0
0
0
0
(0)
0
(0)
0
0
0
(1)
0
(0)
0
0
0
0
Net Change in Cash
(9)
N/A
51
N/A
117
+130%
52
-55%
(6)
N/A
(30)
-406%
(63)
-114%
(40)
+37%
10
N/A
33
+229%
66
+103%
24
-64%
(26)
N/A
(3)
+89%
(88)
-2 986%
(61)
+31%
21
N/A
2
-91%
(15)
N/A
(9)
+36%
(10)
-5%
(16)
-67%
34
N/A
15
-56%
(53)
N/A
2
N/A
(9)
N/A
(52)
-505%
12
N/A
38
+222%
15
-60%
(27)
N/A
(1)
+96%
13
N/A
33
+146%
18
-44%
(14)
N/A
Free Cash Flow
Free Cash Flow
(14)
N/A
12
N/A
26
+115%
40
+52%
11
-73%
27
+156%
46
+68%
60
+30%
54
-11%
48
-10%
41
-15%
14
-67%
32
+135%
63
+98%
7
-88%
(7)
N/A
10
N/A
0
-98%
(5)
N/A
30
N/A
19
-39%
10
-45%
1
-87%
52
+3 846%
(171)
N/A
61
N/A
(37)
N/A
(18)
+50%
13
N/A
(4)
N/A
(5)
-12%
46
N/A
42
-8%
28
-34%
28
+0%
19
-33%
(23)
N/A

See Also

Discover More